E-LIB Suche - Ergebnisse für: Stannard, Kimberley

1

Author Correction: CIS is a potent checkpoint in NK cell–me..:

Delconte, Rebecca B. ; Kolesnik, Tatiana B. ; Dagley, Laura F....
Nature Immunology. 25 (2023) 2 - p. 371-372 , 2023

Link: https://doi.org/10.1038/..

2

CD155 loss enhances tumor suppression via combined host and..:

Li, Xian-Yang ; Das, Indrajit ; Lepletier, Ailin...
Journal of Clinical Investigation. 132 (2022) 6 - p. , 2022

Link: https://doi.org/10.1172/..

3

CD155 on Tumor Cells Drives Resistance to Immunotherapy by ..:

Braun, Matthias ; Aguilera, Amelia Roman ; Sundarrajan, Ashmitha...
Immunity. 53 (2020) 4 - p. 805-823.e15 , 2020

Link: https://doi.org/10.1016/..

4

Systemic administration of IL‐33 induces a population of ci..:

Guillerey, Camille ; Stannard, Kimberley ; Chen, Jason...
Immunology & Cell Biology. 99 (2020) 1 - p. 65-83 , 2020

Link: https://doi.org/10.1111/..

5

Human peripheral blood DNAM-1neg NK cells are a terminally ..:

Stannard, Kimberley A. ; Lemoine, Sébastien ; Waterhouse, Nigel J....
Blood Advances. 3 (2019) 11 - p. 1681-1694 , 2019

Link: https://doi.org/10.1182/..

6

HUMAN PERIPHERAL BLOOD DNAM-1NEG NK CELLS ARE A TERMINALLY ..:

Guillerey, Camille ; Stannard, Kimberley ; Lemoine, Sebastien...
Experimental Hematology. 76 (2019) - p. S68 , 2019

Link: https://doi.org/10.1016/..

7

The immune checkpoint CD96 defines a distinct lymphocyte ph..:

Lepletier, Ailin ; Lutzky, Viviana P ; Mittal, Deepak...
Immunology & Cell Biology. 97 (2018) 2 - p. 152-164 , 2018

Link: https://doi.org/10.1111/..

8

CD96 targeted antibodies need not block CD96-CD155 interact..:

Roman Aguilera, Amelia ; Lutzky, Viviana P. ; Mittal, Deepak...
OncoImmunology. 7 (2018) 5 - p. e1424677 , 2018

Link: https://doi.org/10.1080/..

9

Galectin-1 as a potent target for cancer therapy: role in t..:

Ito, Koichi ; Stannard, Kimberley ; Gabutero, Elwyn...
Cancer and Metastasis Reviews. 31 (2012) 3-4 - p. 763-778 , 2012

Link: https://doi.org/10.1007/..

10

Galectin inhibitory disaccharides promote tumour immunity i..:

Stannard, Kimberley A. ; Collins, Patrick M. ; Ito, Koichi...
Cancer Letters. 299 (2010) 2 - p. 95-110 , 2010

Link: https://doi.org/10.1016/..

11

CD96 is an immune checkpoint that regulates CD8(+) T-cell a..:

Mittal, Deepak ; Lepletier, Ailin ; Madore, Jason...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445751/. , 2019

Link: http://www.ncbi.nlm.nih...

12

Human peripheral blood DNAM-1(neg) NK cells are a terminall..:

Stannard, Kimberley A ; Lemoine, Sébastien ; Waterhouse, Nigel J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560343/. , 2019

Link: http://www.ncbi.nlm.nih...

13

Chemotherapy followed by anti-CD137 mAb immunotherapy impro..:

Guillerey, Camille ; Nakamura, Kyohei ; Pichler, Andrea C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675586/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Chemotherapy followed by anti-CD137 mAb immunotherapy impro..:

Guillerey, Camille ; Nakamura, Kyohei ; Pichler, Andrea C...
Guillerey , C , Nakamura , K , Pichler , A C , Barkauskas , D , Krumeich , S , Stannard , K , Miles , K , Harjunpää , H , Yu , Y , Casey , M , Doban , A I , Lazar , M , Hartel , G , Smith , D , Vuckovic , S , Teng , M W L , Leif Bergsagel , P , Chesi , M , Hill , G R , Martinet , L & Smyth , M J 2019 , ' Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model ' , JCI Insight , vol. 4 , no. 14 , e125932 . https://doi.org/10.1172/jci.insight.125932. , 2019

Link: https://research.tue.nl/..

15

CD96 targeted antibodies need not block CD96-CD155 interact..:

Roman Aguilera, Amelia ; Lutzky, Viviana P ; Mittal, Deepak...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927540/. , 2018

Link: http://www.ncbi.nlm.nih...